For UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Health Sciences Acquisitions Corporation 2

(Exact Name of Registrant as Specified in its Charter)

 

	Delaware		N/A
	(State of Incorporation		(I.R.S. Employer
	or Organization)		Identification No.)

40 10th Avenue

Floor 7

New York, NY 10014
(Address of Principal Executive Offices)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class to be so Registered		Name of Each Exchange on Which Each Class is to be Registered
Ordinary Shares, $.0001 par value		The NASDAQ Stock Market LLC
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ¨
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ¨

 

Securities Act registration statement file number to which this form relates: 333-239922.

 

Securities to be registered pursuant to Section 12(g) of the Act: None.

 

 

 

Item 1.

Description of Registrant's Securities to be Registered.

 

A description of the ordinary shares to be registered hereunder is contained in the section entitled “Description of Ordinary Shares” in the Prospectus included in Health Sciences Acquisitions Corporation 2’s (the “Registrant”) Registration Statement on Form S-1 (Registration No. 333-239922) initially filed with the Securities and Exchange Commission on July 17, 2020, as amended from time to time (the “Registration Statement”). This information is incorporated herein by reference. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that are filed subsequently to the Registration Statement are hereby also incorporated by reference herein.

 

Item 2.

Exhibits.

 

Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on the NASDAQ Stock Market LLC and the security registered hereby is not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Date: August 3, 2020	HEALTH SCIENCES ACQUISITIONS CORPORATION 2
	By:	/s/ Roderick Wong
	Name:	Roderick Wong
	Title:	Chairman and Chief Executive Officer